Original Research
Published on 20 Oct 2022
Survival benefit after neoadjuvant or adjuvant radiotherapy for stage II–III gastroesophageal junction adenocarcinoma: A large population-based cohort study
in Cancer Epidemiology and Prevention
- 1,925 views
- 2 citations